【结 构 式】 |
【分子编号】47678 【品名】2-(7-chloro[1,8]naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone 【CA登记号】 |
【 分 子 式 】C23H22ClN3O2 【 分 子 量 】407.8994 【元素组成】C 67.73% H 5.44% Cl 8.69% N 10.3% O 7.84% |
合成路线1
该中间体在本合成路线中的序号:(VII)Condensation of 7-hydroxy-1,8-naphthyridin-2-amine (I) with phthalic anhydride (II) in refluxing acetic acid gives N-(7-hydroxy-1,8-naphthyridin-2-yl)phthalimide (III), which is treated with refluxing POCl3 to yield the 7-chloro derivative (IV). Reduction of compound (IV) with KBH4 in dioxane affords 2-(7-chloro-1,8-naphthyridin-2-yl)-3-hydroxyisoindolin-1-one (V), which is condensed with 5-methyl-2-hexanone (VI) by means of NaH in DMF to give (±)-2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one (VII) (racemic pagoclone). The treatment of (VII) with NaOH in dioxane/water yields the racemic benzoic acid (VIII). Optical resolution of racemic (VIII) by means of (+)-ephedrine or cinchonine affords the (+)-isomer (IX), which is finally cyclized to the chiral (+)-indolinone derivative pagoclone by means of SOCl2 and imidazole in dichloromethane.
【1】 Silvestre, J.S.; Castaner, J.; Leeson, P.A.; Sorbera, L.A.; Pagoclone. Drugs Fut 2001, 26, 7, 651. |
【2】 Bourzat, J.-D.; Cotrel, C.; Roussel, G.; Capet, M.; Labaudiniere, R.; Pitchen, P. (Aventis SA); Isoindolinone derivs.. AU 8781911; EP 0274930; FR 2607503; JP 1988154681; US 4960779 . |
【3】 David-Comte, M.-T.; Roussel, G. (Aventis Pharma SA); Novel 2-aminonaphthyridine deriv., its preparation and its use. EP 0522969; FR 2678931 . |
【4】 David-Comte, M.-T. (Aventis Pharma SA); Dextrorotatory isomer of a deriv. of 2-amino naphthyridine and its preparation. EP 0522971; FR 2678933 . |
【5】 David-Comte, M.-T. (Aventis Pharma SA); Process for the preparation of a dextrorotatory isomer of an isoindolinone deriv.. EP 0522972; FR 2678934 . |
【6】 David-Comte, M.-T. (Aventis Pharma SA); Process for the preparation of the optical isomers of 2-aminonaphthyridine derivs.. EP 0522970; FR 2678932 . |
【7】 Cotrel, C.; Crisan, C.; Jeanmart, C.; Messer, M.N. (Aventis Pharma SA); Heterocyclic compounds. BE 0835325; DE 2550111; FR 2313060; FR 2322600; FR 2322601; FR 2322602; GB 1468497; JP 7670776; JP 7733685; JP 7998790; JP 8040671; JP 8051087; US 4220646 . |
【8】 (Aventis Pharma SA); Novel isoindoline derivs., their preparation and compsns. containing them. FR 2229400 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 28994 | 7-amino[1,8]naphthyridin-2-ol | C8H7N3O | 详情 | 详情 | |
(II) | 11900 | 2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride | 85-44-9 | C8H4O3 | 详情 | 详情 |
(III) | 47675 | 2-(7-hydroxy[1,8]naphthyridin-2-yl)-1H-isoindole-1,3(2H)-dione | C16H9N3O3 | 详情 | 详情 | |
(IV) | 47676 | 2-(7-chloro[1,8]naphthyridin-2-yl)-1H-isoindole-1,3(2H)-dione | C16H8ClN3O2 | 详情 | 详情 | |
(V) | 11334 | 2-(7-Chloro[1,8]naphthyridin-2-yl)-3-hydroxy-1-isoindolinone | C16H10ClN3O2 | 详情 | 详情 | |
(VI) | 47677 | 2-Methyl-5-Hexanone; 5-Methyl-2-hexanone; 5-Methyl-2-oxohexane; iso-Amyl methyl ketone; Isopentyl methyl ketone; Methyl isoamyl ketone | 110-12-3 | C7H14O | 详情 | 详情 |
(VII) | 47678 | 2-(7-chloro[1,8]naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone | C23H22ClN3O2 | 详情 | 详情 | |
(VIII) | 47679 | (rac)-2-[1-[(7-chloro[1,8]naphthyridin-2-yl)amino]-6-methyl-3-oxoheptyl]benzoic acid | C23H24ClN3O3 | 详情 | 详情 | |
(IX) | 47680 | (+)-2-[1-[(7-chloro[1,8]naphthyridin-2-yl)amino]-6-methyl-3-oxoheptyl]benzoic acid | C23H24ClN3O3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VII)The isoindolinone (VII) (racemic pagoclone) can also be obtained by reaction of isoindolinone (V) with SOCl2 in DMF to provide 3-chloro-2-(7-chloro-1,8-naphthyridin-2-yl)isoindolin-1-one (X), which is condensed with 3-oxo-6-methylheptanoic acid ethyl ester (XI) by means of NaH in DMF to yield 2-[2-(7-chloro-1,8-naphthyridin-2-yl)-3-oxoisoindolin-1-yl-6-methyl-3-oxoheptanoic acid ethyl ester (XII). Finally, this compound is decarboxylated to the indolinone (VII) by means of LiCl in refluxing DMSO/water. The racemic benzoic acid (VIII) can also be obtained by hydrolysis of the heptanoic ester (XII) with concentrated sulfuric acid to give the corresponding free acid (XIII), which is finally decarboxylated and hydrolyzed by means of NaOH in water.
【1】 Silvestre, J.S.; Castaner, J.; Leeson, P.A.; Sorbera, L.A.; Pagoclone. Drugs Fut 2001, 26, 7, 651. |
【2】 Bourzat, J.-D.; Cotrel, C.; Roussel, G.; Capet, M.; Labaudiniere, R.; Pitchen, P. (Aventis SA); Isoindolinone derivs.. AU 8781911; EP 0274930; FR 2607503; JP 1988154681; US 4960779 . |
【3】 David-Comte, M.-T. (Aventis Pharma SA); Dextrorotatory isomer of a deriv. of 2-amino naphthyridine and its preparation. EP 0522971; FR 2678933 . |
【4】 David-Comte, M.-T.; Roussel, G. (Aventis Pharma SA); Novel 2-aminonaphthyridine deriv., its preparation and its use. EP 0522969; FR 2678931 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 11334 | 2-(7-Chloro[1,8]naphthyridin-2-yl)-3-hydroxy-1-isoindolinone | C16H10ClN3O2 | 详情 | 详情 | |
(VII) | 47678 | 2-(7-chloro[1,8]naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone | C23H22ClN3O2 | 详情 | 详情 | |
(VIII) | 47679 | (rac)-2-[1-[(7-chloro[1,8]naphthyridin-2-yl)amino]-6-methyl-3-oxoheptyl]benzoic acid | C23H24ClN3O3 | 详情 | 详情 | |
(X) | 47681 | 3-chloro-2-(7-chloro[1,8]naphthyridin-2-yl)-1-isoindolinone | C16H9Cl2N3O | 详情 | 详情 | |
(XI) | 47682 | Ethyl isoamylacetoacetate; ethyl 6-methyl-3-oxoheptanoate | C10H18O3 | 详情 | 详情 | |
(XII) | 47683 | ethyl 2-[2-(7-chloro[1,8]naphthyridin-2-yl)-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-6-methyl-3-oxoheptanoate | C26H26ClN3O4 | 详情 | 详情 | |
(XIII) | 47684 | 2-[2-(7-chloro[1,8]naphthyridin-2-yl)-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-6-methyl-3-oxoheptanoic acid | C24H22ClN3O4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(VII)The optical resolution of racemic pagoclone (VII) can also be performed by reaction with (-)-(1R,2R,3S,5R)-pinanediol (XIV) by means of PPTS in refluxing dichloroethane to give the ketal (XV) as a diastereomeric mixture separated by crystallization. Finally, hydrolysis of the desired diastereomer (XVI) with 12N HCl affords the (+)-enantiomer, pagoclone.
【1】 Silvestre, J.S.; Castaner, J.; Leeson, P.A.; Sorbera, L.A.; Pagoclone. Drugs Fut 2001, 26, 7, 651. |
【2】 Barreau, M.; Cotrel, C.; Dubroeucq, M.-C.; Manfre, F. (Aventis Pharma SA); Method for preparing enantiomers of an isoindolinone deriv.. WO 9313098 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 47678 | 2-(7-chloro[1,8]naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone | C23H22ClN3O2 | 详情 | 详情 | |
(XIV) | 16644 | (-)-Pinanediol; (1R,2R,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol | 20536-52-1 | C10H18O2 | 详情 | 详情 |
(XV) | 47685 | (rac)-2-(7-chloro[1,8]naphthyridin-2-yl)-3-[[(1R,2R,6S,8R)-4-isopentyl-2,9,9-trimethyl-3,5-dioxatricyclo[6.1.1.0(2,6)]dec-4-yl]methyl]-1-isoindolinone | C33H38ClN3O3 | 详情 | 详情 | |
(XVI) | 47686 | (+)-2-(7-chloro[1,8]naphthyridin-2-yl)-3-[[(1R,2R,6S,8R)-4-isopentyl-2,9,9-trimethyl-3,5-dioxatricyclo[6.1.1.0(2,6)]dec-4-yl]methyl]-1-isoindolinone | C33H38ClN3O3 | 详情 | 详情 |